Seeking Alpha

MBLTY
  Mesoblast Ltd. ADR - OTCPK - Current

9/16/2014, 11:39 PM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
MBLTY vs. ETF Alternatives
Company Description
Mesoblast is developing a series of high margin, off-the-shelf adult stem cell products that are obtained from a single donor, commercially expanded and frozen, and subsequently used in potentially thousands of unrelated, or allogeneic, recipients at the time and place of need.
Sector: Healthcare
Industry: Biotechnology
Country: Australia